Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P337: Efficacy of intravenous cyclosporine in fulminant steroid-refractory ulcerative colitis with massive bleeding: a retrospective, observational studyECCO '17 Barcelona
Year: 2017
Authors:

Ogashiwa T., Nishio M., Otake H., Inoue E., Kimura H., Kunisaki R.

Yokohama City University Medical centre, Inflammatory Bowel Disease Centre, Yokohama, Japan

P338: Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversalECCO '17 Barcelona
Year: 2017
Authors:

Dirrenberger B.*1, Clerc-Urmès I.2, Germain A.3, Bresler L.3, Olivera P.1, Martelli L.1, Baumann C.2, Laurent V.4, Peyrin-Biroulet L.1

1Nancy University Medical Center, Department of Hepatogastroenterology, Nancy, France 2Nancy University Medical Center, ESPRI-BioBase Unit, PARC Clinical Research Support Facility, Nancy, France 3Nancy University Medical Center, Department of Digestive Surgery, Nancy, France 4Nancy University Medical Center, Department of Radiology, Nancy, France

P339: MadCAM1 expression in intestinal lamina propria endothelium varies among inflammatory bowel disease patientsECCO '17 Barcelona
Year: 2017
Authors:

Zamborsky T.1,2, Berakova K.3, Kadleckova B.2, Podmanicky D.4, Zelinkova Z.*1

1St. Michael's Hospital, Department of Gastroenterology, Bratislava, Slovakia 2Assiduo, IBD Center, Bratislava, Slovakia 3MBC, Zilina, Slovakia 4St. Michael's Hospital, Department of Surgery, Bratislava, Slovakia

P340: Prevalence and long-term effect of antiplatelet use in inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Mantaka A., Renieri V., Koutroubakis I.

University Hospital of Heraklion, Department of Gastroenterology, Heraklion, Greece

P341: Combination of corticosteroids and 5-aminosalycilates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: a global survey of physicians' practiceECCO '17 Barcelona
Year: 2017
Authors:

Ben-Horin S.*1,2, Andrews J.M.3, Katsanos K.H.4, Rieder F.5, Steinwurz F.6, Karmiris K.7, Cheon J.H.8, Moran G.W.9, Cesarini M.10, Stone C.D.11, Schwartz D.12, Protic M.13, Roblin X.14, Roda G.15, Chen M.2, Har-Noy O.1, Bernstein C.N.16

1Sheba Medical Center, Tel-Hashomer, Israel 2The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China 3Royal Adelaide Hospital, School of Medicine, University of Adelaide, Adelaide, Australia 4University of Ioannina, Ioannina, Greece 5Cleveland Clinic Foundation, Cleveland, United States 6Hospital Israelita Albert Einstein, São Paulo, Brazil 7Venizeleio General Hospital, Heraklion, Crete, Greece 8Yonsei University College of Medicine, Seoul, South Korea 9Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, United Kingdom 10“Sapienza”, University of Rome, Rome, Italy 11Comprehensive Digestive Institute of Nevada, Las-Vegas, United States 12Soroka University Medical Center, Beer-Sheva, Israel 13University Hospital Zvezdara, Belgrade, Serbia 14University-Hospital of Saint-Etienne, Saint-Etienne, France 15S.Orsola-Malpighi Hospital, Bologna, Italy 16University of Manitoba, Winnipeg, Canada

P342: Maladaptive coping, self-efficacy and patient reported outcomes in inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Chao C.-Y.*1,2, Lemieux C.1, Afif W.1, Bitton A.1, Wild G.1, Bessissow T.1

1McGill University Health Centre, Department of Gastroenterology, Montréal, Canada 2Princess Alexandra Hospital, Department of Gastroenterology, Brisbane, Australia

P343: Female gender, somatization and presence of IBS-type symptoms predicts Dyspareunia in patients with IBDECCO '17 Barcelona
Year: 2017
Authors:

O'Connor A.*1, Gracie D.1, Hamlin J.1, Selinger C.1, Ford A.1,2

1Leeds Gastroenterology Institute, Leeds, United Kingdom 2University of Leeds, Leeds Institute of Biochemical and Clinical Sciences, Leeds, United Kingdom

P344: Vitamin D-Induced alterations in Cytokine levels lower the risk of clinical relapse in ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Gubatan J.M., Mitsuhashi S., Longhi M.S., Zenlea T., Rosenberg L., Robson S., Moss A.

Beth Israel Deaconess Medical Center, Harvard Medical School, Division of Gastroenterology, Department of Medicine, Boston, United States

P345: Inconsistency between electronic data of patient's adherence and self reported adherence scoreECCO '17 Barcelona
Year: 2017
Authors:

Broide E.*1,2, Ein Dor A.1,3, Ruhimovich N.4, Shitrit A.B.5, Benjaminov F.2, Matalon S.1,3, Shirin H.1,2, Konikoff F.M.3,6, Naftali T.6

1Assaf Harofeh Medical Center, The Kamila Gonczarowski institute of Gastroenterology Assaf Harofeh Medical Center, Zerifin, Israel 2Tel Aviv university Sackler school of medicin, internal medicine, Tel aviv, Israel 3Tel Aviv university Sackler school of medicin, internal medicine, Tel Aviv, Israel 4Meir Medical Center, Department of Gastroenterology & Hepatology, Kfar Saba, Israel 5Shaare Zedek Medical Center, Department of Gastroenterology and Digestive Diseases, Jerusalem, Israel 6Meir medical center, Gastroenterology, Kfar Saba, Israel

P346: Dietary practices and beliefs among parents of children with inflammatory bowel disease: preliminary resultsECCO '17 Barcelona
Year: 2017
Authors:

Pituch-Zdanowska A.*1, Stawicka A.1, Jarocka-Cyrta E.2, Banaszkiewicz A.1

1Medical University of Warsaw, Department of Pediatric Gastroenterology and Nutrition, Warsaw, Poland 2Faculty of Medical Science University of Warmia and Mazury, Department of Pediatrics, Gastroenterology and Nutrition, Olsztyn, Poland

P347: Evaluation of step up therapy in patients with early ulcerative colitis: a prospective cohort studyECCO '17 Barcelona
Year: 2017
Authors:

Bossuyt P.*1,2, Baert F.3, Coenegrachts J.-L.4, De Vos M.5, Dewit O.6, Ferrante M.7, Fontaine F.8, Mana F.9, Vandervoort J.10, Moreels T.11 Belgian IBD Research and Development Group

1University Hospitals Leuven, Department of Gastroenterology, Leuven, Belgium 2Imelda GI Clinical Research Center, Department of Gastroenterology, Bonheiden, Belgium 3AZ Delta, Department of Gastroenterology, Roeselare, Belgium 4Jessa Hospital Hasselt, Department of Gastroenterology, Hasselt, Belgium 5Ghent University Hospital, Gastroenterology, Ghent, Belgium 6UCL Saint-Luc, Department of Gastroenterology, Brussels, Belgium 7UZ Leuven, Campus Gasthuisberg, Department of Gastroenterology and Hepatology, Leuven, Belgium 8CHC Site St. Joseph, Department of Gastroenterology, Liège, Belgium 9UZ Brussels, Department of Gastroenterology, Brussels, Belgium 10OLV Hospital Aalst-Asse-Ninove, Departement Of Gastroenterology, Aalst, Belgium 11University Hospital Antwerp, Department of Gastroenterology and Hepatology, Edegem, Belgium

P348: Persistent hyperCKemia during infliximab therapy in patients with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Theodoraki E., Orfanoudaki E., Foteinogiannopoulou K., Koutroubakis I.

University Hospital of Heraklion, Greece, Gastroenterology, Heraklion, Crete, Greece, Greece

P349: The therapies influencing postoperative surgical recurrence in Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Shinozaki M.

The Institute of Medical Science, The University of Tokyo, Department of Surgery, Tokyo, Japan

P350: Induction of antiphospholipid antibodies in patients with inflammatory bowel disease treated with anti-TNFα agentsECCO '17 Barcelona
Year: 2017
Authors:

Robles V., Herrera deGuise C., Guirola M.A., Borruel N., Casellas F.

Unitat d'Atenciό Crohn-Colitis. Hospital Universitari Vall d'Hebron, Digestive Diseases Research, Barcelona, Spain

P351: Do self-selected “Non-Transitioned” referrals from peadiatric services have lower treatment requirements?ECCO '17 Barcelona
Year: 2017
Authors:

Shaikh O.1, Harvey P.*1, Cooney R.1, Muhammed R.2

1University Hospital Birmingham, Gastroenterology, Birmingham, United Kingdom 2Birmingham Children's Hospital NHS Trust, Paediatric Gastroenterology, Birmingham, United Kingdom

P352: Assessment of the use of therapeutic drug monitoring of Adalimumab during maintenance therapy in children with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Chavannes M.*1, Gervais F.1, Verreault A.2, Deslandres C.1, Jantchou P.2

1Sainte Justine University Hospital, Pediatric Gastroenterology, Montreal, Canada 2Sainte Justine University Hospital, Research Center of the CHU Sainte Justine, Montreal, Canada

P353: Long-term safety of adalimumab in patients with Crohn's disease: final data from PYRAMID registryECCO '17 Barcelona
Year: 2017
Authors:

D'Haens G.*1, Reinisch W.2, Satsangi J.3, Loftus Jr. E.V.4, Panaccione R.5, Alperovich G.6, Kalabic J.7, Bereswill M.7, Arikan D.8, Petersson J.8, Robinson A.M.8

1Academic Medical Centre, Department of Gastroenterology, Amsterdam, Netherlands 2Medical University of Vienna, Vienna, Austria 3Western General Hospital, Gastrointestinal Unit, Edinburgh, United Kingdom 4Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, United States 5University of Calgary, Department of Medicine, Calgary, Canada 6AbbVie Spain S.L.U., Madrid, Spain 7AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany 8AbbVie Inc., North Chicago, United States

P354: The effect of value based health care delivery for inflammatory bowel diseases on outcomes of patientsECCO '17 Barcelona
Year: 2017
Authors:

Zand A., Aredas E., Duran N., DiNicola C., Lacey P., Arenas A., Hommes D.W.

UCLA Center for Inflammatory Bowel Diseases, Los Angeles, United States

P355: A structured care pathway improves quality of care for acute severe ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Neary B., Doherty G., Rafter N., Gibson D.

St Vincent's University Hospital, Gastroenterology, Dublin, Ireland

P356: Treatment with anakinra induces T cell production of IL22 and GI mucosal healing in an IL-10RA mutation patientECCO '17 Barcelona
Year: 2017
Authors:

Li J.1, Shouval D.2, Doty A.1, Snapper S.3, Glover S.*1

1University of Florida, Gainesville, United States 2Tel Aviv University, Tel Aviv, Israel 3Harvard University, Boston, United States